Pharma
Pharma·
Eli Lilly Moves to Acquire AtaiBeckley, Signaling a Shift in Psychedelic Medicine
Pharma·
Johnson & Johnson: Strong Growth Despite Challenges in the Psoriasis Segment
Pharma·
Johnson & Johnson: Strong Quarter Despite Challenges in the Psoriasis Segment
Pharma·
Boehringer Ingelheim: Focus on Growth Markets Outside Europe
Pharma·
Biogen Faces Setback as Alzheimer’s Drug Trial Data Disappoints Investors
Pharma·
AstraZeneca Expands Portfolio with $1.5 Billion Lung Cancer Drug Acquisition
Pharma·
Oxford Initiates Groundbreaking Human Trial for Bundibugyo Ebola Vaccine Amid Ongoing Outbreak
Pharma·
Novartis Receives Approval for Kidney Drug Vanrafia in Canada
Pharma·
Kenvue Faces Legal Headwinds as Autism Claims Resurface
Pharma·
Apnimed Aims for IPO to Propel Sleep Apnea Drug Development
Pharma·
BioOrbit's Zero Gravity Breakthrough: A New Frontier in Cancer Treatment
Pharma·
UK Minister Defends Controversial US Pharma Deal Amid Criticism
Pharma·
Major Drugmaker Faces $27 Billion Market Value Erosion Following Failed Heart Drug Trial
Pharma·
Astrazeneca: Disappointing Study Data for Wainua Weighs on Stock Price
Pharma·
Dr. Reddy's Laboratories Faces Setback in Generic Ozempic Production
Pharma·
Boehringer Ingelheim Warns of Negative Consequences of Health Insurance Reform
Pharma·
AstraZeneca and Daiichi Poised for UK Price Agreement on Life-Saving Breast Cancer Drug
Pharma·
India's Obesity Drug Market Faces Slowdown Amid Generic Surge
Pharma·
Compass Pathways Shares Plummet Following Underwhelming Psilocybin Study Results
Pharma·
Island Pharma Soars 47% Following Emergency-Use Approval for Ebola Treatment
Pharma·
Vertex Pharmaceuticals Expands Endocrinology Portfolio with $10 Billion Crinetics Acquisition
Pharma·
Novartis Strengthens Oncology Pipeline Through Acquisition of Myricx Bio for Up to $1.5 Billion
Pharma·
Novartis Expands Oncology Portfolio with $1.5 Billion Acquisition of Myricx Bio
Pharma·
BioNxt Solutions Inc. Advances Sublingual Semaglutide Program: An Innovative Step in Drug Delivery
Pharma·
Accelerating Ebola Vaccine Trials: A Race Against Time and Disease
Pharma·
The Billion-Dollar Peptide Craze Could Get Even Bigger
Pharma·
Roche Achieves Breakthrough in Lung Cancer Treatment with Divarasib
Pharma·
Novo Nordisk Seeks Supplier Discounts Amid Intensifying Obesity Drug Competition
Pharma·
Novo Nordisk's Major Stakeholder Invests in Italian Accelerator to Ignite Drug Innovation
Pharma·
Sixth Street and KKR Inject $1 Billion into BridgeBio: A Strategic Boost for Biotechnology
